Characterization of the B Cell Receptor Repertoire in the Intestinal Mucosa and of Tumor-Infiltrating Lymphocytes in Colorectal Adenoma and Carcinoma

The B cells inhabited in mucosa play a vital role in mediating homeostasis with autoantigens and external Ags. Tumor-infiltrating lymphocytes are potential prognostic markers and therapeutic agents for cancer. However, the spatial heterogeneity of the B cell repertoire in intestinal mucosa and the tumor-infiltrating lymphocytes in colorectal cancer (CRC) remain poorly understood. In this study, we developed an unbiased method to amplify the IgH repertoire, as well as a bioinformatic pipeline to process these high-throughput sequencing data. With biopsies from seven intestinal mucosal segments, we uncovered their strong spatial homogeneity among the large intestine, where the clone overlap rate was up to 62.21%. The heterogeneity between terminal ileum and large intestine was also observed, including discrepant isotype distribution and low clone overlap rate. With tumor and adjacent normal mucosal tissues from CRC and colorectal advanced adenoma (AD) patients, we observed a similar IgH profile between tumor and adjacent normal mucosal tissues in AD, as well as a slight difference in CRC. Interestingly, we found distinct repertoire properties in the CRC tumor from AD and normal mucosa. Finally, we identified 1445 public clones for the normal mucosa, and 22 public clones for the CRC tumor with characteristic features. These data may be of potential use in clinical prognosis, diagnosis, and treatment of CRC.

[1]  N. Stollman,et al.  Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. , 1999, The American journal of gastroenterology.

[2]  R. Emerson,et al.  High‐throughput sequencing of T‐cell receptors reveals a homogeneous repertoire of tumour‐infiltrating lymphocytes in ovarian cancer , 2013, The Journal of pathology.

[3]  S. Quake,et al.  The promise and challenge of high-throughput sequencing of the antibody repertoire , 2014, Nature Biotechnology.

[4]  Laurie J. Heyer,et al.  Exploring expression data: identification and analysis of coexpressed genes. , 1999, Genome research.

[5]  J. Bond.  Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps , 2000, American Journal of Gastroenterology.

[6]  Herbert Tilg,et al.  Gut microbiome development along the colorectal adenoma-carcinoma sequence , 2015 .

[7]  Johannes Trück,et al.  In-Depth Assessment of Within-Individual and Inter-Individual Variation in the B Cell Receptor Repertoire , 2015, Front. Immunol..

[8]  H. Wardemann,et al.  The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. , 2011, The Journal of clinical investigation.

[9]  Stephen R. Quake,et al.  Genetic measurement of memory B-cell recall using antibody repertoire sequencing , 2013, Proceedings of the National Academy of Sciences.

[10]  P. Brandtzaeg,et al.  Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties , 2005, Immunological reviews.

[11]  M. Vignali,et al.  T‐cell receptor profiling in cancer , 2015, Molecular oncology.

[12]  G. D. de Bock,et al.  The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis , 2011, British Journal of Cancer.

[13]  A. Zauber,et al.  The advanced adenoma as the primary target of screening. , 2002, Gastrointestinal endoscopy clinics of North America.

[14]  W. Caspary,et al.  IgA and IgM V(H) repertoires in human colon: evidence for clonally expanded B cells that are widely disseminated. , 2000, Gastroenterology.

[15]  S. Mazmanian,et al.  Gut biogeography of the bacterial microbiota , 2015, Nature Reviews Microbiology.

[16]  Zlatko Trajanoski,et al.  Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  F. Burnet.  The concept of immunological surveillance. , 1970, Progress in experimental tumor research.

[18]  L. Duan,et al.  Bacterial Community Mapping of the Mouse Gastrointestinal Tract , 2013, PloS one.

[19]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[20]  Ting Wang,et al.  The Different T-cell Receptor Repertoires in Breast Cancer Tumors, Draining Lymph Nodes, and Adjacent Tissues , 2016, Cancer Immunology Research.

[21]  H. Schroeder.  Similarity and divergence in the development and expression of the mouse and human antibody repertoires. , 2006, Developmental and comparative immunology.

[22]  J. Galon,et al.  The essential role of the in situ immune reaction in human colorectal cancer , 2008, Journal of leukocyte biology.

[23]  Peter Schirmacher,et al.  Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue , 2013, Cancer Immunology, Immunotherapy.

[24]  E. S. Baekkevold,et al.  Regional specialization in the mucosal immune system: what happens in the microcompartments? , 1999, Immunology today.

[25]  Sai T Reddy,et al.  Accurate and predictive antibody repertoire profiling by molecular amplification fingerprinting , 2016, Science Advances.

[26]  Nolan G. Ericson,et al.  Digital Genomic Quantification of Tumor-Infiltrating Lymphocytes , 2013, Science Translational Medicine.

[27]  Charles Swanton,et al.  Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas , 2013, The Journal of pathology.

[28]  Xun Xu,et al.  IMonitor: A Robust Pipeline for TCR and BCR Repertoire Analysis , 2015, Genetics.